Polymorphonuclear leukocytes produce thromboxane A2-like activity during phagocytosis.

[1]  J. Vane.  THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD , 1997, British journal of pharmacology and chemotherapy.

[2]  J. Vane,et al.  Prostaglandin endoperoxide and thromboxane generating systems and their selective inhibition. , 1976, Prostaglandins.

[3]  M. Hamberg,et al.  Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides , 1976, Nature.

[4]  B. Fredholm,et al.  Isomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albumin. , 1976, Biochimica et biophysica acta.

[5]  M. Hamberg,et al.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Youlten,et al.  A CHEMOTACTIC ROLE FOR PROSTAGLANDINS RELEASED FROM POLYMORPHONUCLEAR LEUCOCYTES DURING PHAGOCYTOSIS , 1975, British journal of pharmacology.

[7]  M. Hamberg,et al.  Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Vane,et al.  Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs , 1969, Nature.

[9]  J. Vane,et al.  Prostaglandins released by the Spleen , 1968, Nature.

[10]  J. G. Hirsch,et al.  STUDIES OF PHAGOCYTOSIS OF GROUP A STREPTOCOCCI BY POLYMORPHONUCLEAR LEUCOCYTES IN VITRO , 1960, The Journal of experimental medicine.